The pancreatic hormone, glucagon, stimulates the net uptake of inorganic 32P in vivo into rat liver and its incorporation into proteins of microsomes, mitochondrial membranes, and lysosomes. Incorporation into cytosolic proteins was enhanced only slightly by glucagon.
Glucagon, the hormone produced by pancreatic islet alpha cells, stimulates glycogenolysis, lipolysis, and gluconeogenesis, and induces the synthesis of several enzymes in mammalian liver (1, 2) .
Sutherland and coworkers (3) have demonstrated that the effects of glucagon are mediated through cyclic adenosine monophosphate (cAMP), formed by glucagon-activated adenyl cyclase in the liver plasma membrane (4) . One of the actions of adenyl cyclase is to activate protein kinases (5) that specifically phosphorylate certain enzymes (6) , histones (7) , ribosomal proteins (8, 9) , membrane proteins of neurotubules (10) , and renal medullary plasma membranes (11) .
Recently, Guder et al. (12) and Vavrfnkovd and Mosinger (13) found that glucagon treatment stimulates the release of lysosomal enzymes. The lipolytic and proteolytic activity of these released enzymes probably lead to the increased ketogenesis and urea output observed in perfused livers supplemented with glucagon (14) . Electron microscopy of liver tissue removed from animals treated with glucagon reveals rapid and striking swelling of lysosomes up to 800% of their normal volume and alterations of liver cell structure (15) (16) (17) . During an investigation of the function of glucagon, we have observed that this hormone strikingly enhances the phosphorylation of mitochondrial, microsomal, and lysosomal membranes in rat liver. Thus, membrane protein phosphorylation may be a general mechanism for the mediation of the action of glucagon on the liver cell. MATERIALS (23) . Mitochondrial membrane preparations were checked for purity with the polyacrylamide electrophoresis system of Schnaitman (24) . Monoamine oxidase distribution was determined according to Tabor et al. (25) and Allman et al. (26) . Rat liver lysosomes were prepared and purified to lysosomal "pellet 2" as reported by Ragab et al. (27) Fig. 2A-F) . The most striking effects of glucagon were seen in microsomal, mitochondrial, and lysosomal proteins. When lysosoines were treated with sonic oscillation, sedimented, and washed before the extraction procedure was started, all of the original radioactivity (within experimental counting error) was retained in the sedimented membrane fraction and little or none was found in the soluble fraction. Thus, in both lysosomes (insert, Fig. 2B ) and mitochondria ( Fig. 2E and F responding effects of glucagon were found for hepatic microsomes and for the inner and outer membrane fraction of mitochondria. The relative distribution of label in the different extracts of the lysosomes is quite different from all the other cell components. Although glucagon enhanced total radioactivity in lysosomes, there were no apparent differences in percentage distribution of 32p between the lysosomes of untreated and glucagon-treated animals. About 99% of the total radioactivity of the cytosol (105,000 X g for 1 hr) and the soluble mitochondrial fraction was in the 5% C13CCOOH soluble fraction (data not shown).
Distribution of 32p in-Phospholipids. Although the total incorporation of 32p into phospholipids was enhanced by glucagon and by But2cAMP, the percentage distribution among the various phospholipids was not affected by these agents. Table 2 presents the 82p distribution in various phospholipids from the mitochondria and lysosomes. The distribution in microsomes and mitochondrial membranes (not shown) was similar to that of whole mitochondria. In the latter, the highest percentage of 32p incorporated was always found in compounds with the mobility of phosphatidyl ethanolamine, phosphatidyl inositol, and phosphatidyl choline. Sphingomyelin plus lysophosphatidyl-choline contained about half of the radioactivity of each of the three phosphocontaining neutral lipids, cardiolipin, and phosphatidic acid incorporated the least 82p. 
DISCUSSION
In the present study it has been shown that glucagon treatment in vivo for different periods of time increases the incorporation of 82p into proteins and other components of mitochondria, microsomes, and lysosomes ( Fig. 2A-F) . The increased incorporation into proteins caused by glucagon is accounted for by 32p in phosphoserine residues. Increased incorporation of 32p into the proteins could be the result of two different processes: (1) increase of the specific activity of the intracellular phosphate pool through facilitated uptake of 82p into the liver in the presence of glucagon; or (2) specific hormonal stimulation of intracellular protein phosphorylating processes. It is known (28, 29) that glucagon decreases serum phosphate and increases uptake of phosphate in liver and heart. Rats subjected to the effects of glucagon for 90 min took up 30% more 32p into their livers than the controls (data not shown). This enhanced uptake of 82p into the liver cell was not sufficient to account for the glucagon-induced increase of the specific activities in the proteins of microsomes (84%), mitochondria (184%), soluble mitochondrial fraction (237%), and outer (340%) and inner (162%) mitochondrial membranes, nor was it sufficient to account for the increased incorporation of 82p into hot C13CCOOH extracts and ethanol-ether soluble lipids (Table 1 ). An influence of glucagon on phosphorylation processes is clearly demonstrated by the fact that this hormone decreased the percent of 82p found in the fractions containing inorganic phosphate. Glucagon-dependent activation of protein-phosphorylating processes via ATP (5) are, therefore, very likely the main mechanism for increasing the 82p incorporation into the membrane proteins reported here, as was shown in the case of glucagon-stimulated histone phosphorylation in vivo (7) . Langan (7) also found that glucagon does not produce significant changes in the specific activity of the liver phosphate pools. Although glucagon enhanced the incorporation lipids mentioned above. Phosphatidyl serine and the fraction Proc. Nat. Acad. Sci. USA 69 (1972) of IT into the lipid fraction of mitochondria and of lysosomes, it had no differential effect on the distribution of the isotope in various phospholipids isolated ( Table 2 ). The extreme difference in distribution of 32p in phospholipids of the lysosomes (Table 2) , compared with mitochondria, can be explained on the basis of a completely different phospholipid composition of the lysosomal membrane, as was reported by Henning et al. (30) . The fact that glucagon enhances 82p incorporation in the microsomal and soluble mitochondrial proteins without influencing the total amount of alkali-labile phosphate (Table 3) indicates a rapid turnover of phosphate in these proteins induced by the hormone. But2cAMP, which generally induces glucagon-like effects in the liver (1, 14) , is, under our experimental conditions, much less effective than glucagon. The increases of specific activities of phosphate-labeled proteins in mitochondria (Fig. 2C) , as well as in outer and inner membrane ( Fig. 2E  and F) , after injection of But2cAMP are much less impressive than that occurring after injection of glucagon. The possibility of different time curves for cAMP accumulation and degradation in the liver cell after the use of glucagon or But2cAMP makes a valid comparison of time-dependent effects of these All rats were killed 90 min after receiving 321p; glucagon was given 30 min before they were killed. Each number represents three pooled livers (for lysosomes, seven livers).
agents on protein-phosphorylating processes difficult. Such time differences could explain our failure to detect a significant effect of But2cAMP on 32p incorporation into microsomal proteins ( Fig. 2A ) at the only time tested. The glucagon-stimulated phosphorylation of mitochondrial and lysosomal proteins, which intracellularly is probably mediated through cAMP-activated protein kinases (5) , can be integrated into the whole pattern of known glucagon effects in rat liver. The catabolic effects of glucagon in rat liver (14) , the release of lysosomal enzymes (15) (16) (17) , and the facilitated uptake of pyruvate into mitochondria (31) may all be influenced by the state of phosphorylation of various. cellular membranes. Phosphorylation of serine residues, mediated through protein kinases, of lysosomal membrane proteins could change membrane properties with increased permeability through enhanced osmotic sensitivity and subsequent swelling (15) . The glucagon-induced release of lysosomal enzymes initiates autophagocytosis in rat liver (12, 13) and leads to the well-known increase of urea output (32) and ketogenesis (14) . Phosphorylation of mitochondrial membranes or, alternatively, the proteolytic or lipolytic action of lysosomal enzymes could enhance the permeability of mitochondrial membranes and thereby increase pyruvate uptake and carboxylation (31) . Electronmicrographs (15) (16) (17) confirm digestion of mitochondria in the neighborhood of swollen lysosomes after glucagon injection.
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